Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis

Adhesive Capsulitis of Shoulder Clinical Trial

Official title:

Effects Of Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04578366
• Other study ID #: RE-MS-OMPT/Spring19/032 Adnan
• Status: Completed
• Phase: N/A
• Start date: October 15, 2019
• Est. completion date: June 28, 2020

Study information

• Verified date: October 2020
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Adhesive capsulitis refers to the occurrence of pain and a gradual decline in the range of motion (ROM) due to slow increases in synovial hypertrophy and the adhesion between the synovial membrane and articular surface. It leads to the loss of flexibility and difficulties with the activities of daily living (ADLs) due to chronic inflammation accompanied by intra-articular fibrosis. The real cause of this syndrome is unknown but there are some predisposing factors involved such as synovial cell hyperplasia, fibrosis of the capsule due to cytokines or other inflammatory factors. In the current study investigator will compare the effects of Extracorporeal Shockwave Therapy (ESWT) along with conventional therapy to treat the adhesive capsulitis.

Description:

This study will be a Randomized Controlled Trail conducted at Horizon hospital, Lahore. The study will be completed within the time duration of Six months. Consecutive sampling technique will be used to collect the data. The sample size of 44 patients will be taken in this study to find the effects of ESWT on pain, ROM, functional mobility. Patient will be divided into two groups. Group A will be treated with ESWT with conventional therapy and Group B will be treated with conventional therapy. Constant Shoulder Score (CSS) and the Oxford Shoulder Score (OSS) tools will be used to measure the outcomes of the study.

One session of treatment per week for four weeks will be given. Pretest, posttest at 4th week and followup of 24th weeks will be evaluated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: June 28, 2020
• Est. primary completion date: June 20, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years to 65 Years

Eligibility

Inclusion Criteria:

• Relapsed or episode of pain score =5 at assessment with a past history of pain for at least 2 months.

• ROM restriction (>75% ROM loss in =2 directions including abduction, flexion and external rotation)

• No treatment other than analgesics with unresponsive ROM restriction for the past 2months.

• Unwilling or waiting and did not undergo joint injection.

Exclusion Criteria:

• bilateral shoulder involvement

• History of previous surgery on the shoulder

• Shoulder fracture

• Cancer

• Glenohumeral or Acromioclavicular arthritis

• Inflammatory disorders

• Bleeding disorders

• Diabetes mellitus

• Presence of severe osteoporosis

• Pulmonary diseases

• Any neuromuscular disorders

• Pregnancy

• Implanted pacemaker

Related Conditions & MeSH terms

• Adhesive Capsulitis of Shoulder
• Bursitis

Intervention

Device:
• Extracorporeal Shockwave Therapy
ESWT along with conventional therapy ESWT + hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder

Other:
• Conventional Treatment
hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder

Locations

Country	Name	City	State
Pakistan	Riphah IU	Lahore

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

References & Publications (7)

Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT. Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis? Rheumatol Int. 2006 Apr;26(6):536-40. Epub 2005 Aug 10. — View Citation

Chen CY, Hu CC, Weng PW, Huang YM, Chiang CJ, Chen CH, Tsuang YH, Yang RS, Sun JS, Cheng CK. Extracorporeal shockwave therapy improves short-term functional outcomes of shoulder adhesive capsulitis. J Shoulder Elbow Surg. 2014 Dec;23(12):1843-1851. doi: 10.1016/j.jse.2014.08.010. — View Citation

Hussein AZ, Donatelli RA. The efficacy of radial extracorporeal shockwave therapy in shoulder adhesive capsulitis: a prospective, randomised, double-blind, placebo-controlled, clinical study. European Journal of Physiotherapy. 2015;18(1):63-76.

Lee S, Lee S, Jeong M, Oh H, Lee K. The effects of extracorporeal shock wave therapy on pain and range of motion in patients with adhesive capsulitis. J Phys Ther Sci. 2017 Nov;29(11):1907-1909. doi: 10.1589/jpts.29.1907. Epub 2017 Nov 24. — View Citation

Massoud SN, Pearse EO, Levy O, Copeland SA. Operative management of the frozen shoulder in patients with diabetes. J Shoulder Elbow Surg. 2002 Nov-Dec;11(6):609-13. — View Citation

Santoboni F, Balducci S, D'Errico V, Haxhi J, Vetrano M, Piccinini G, Ferretti A, Pugliese G, Vulpiani MC. Extracorporeal Shockwave Therapy Improves Functional Outcomes of Adhesive Capsulitis of the Shoulder in Patients With Diabetes. Diabetes Care. 2017 Feb;40(2):e12-e13. doi: 10.2337/dc16-2063. Epub 2016 Nov 29. — View Citation

Wohlgethan JR. Frozen shoulder in hyperthyroidism. Arthritis Rheum. 1987 Aug;30(8):936-9. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Constant Shoulder Score (CSS)	The functional outcome of shoulder. Grading the Constant Shoulder Score (Difference between normal and Abnormal Side); >30 Poor 21-30 Fair 11-20 Good <11 Excellent	8 months
Primary	Range of motion	Oxford Shoulder Score (OSS), increasing score shows improvement, decrease in scores shows deterioration.	8 months
Secondary	NPRS-numeric pain rating scale	This scale ranges 0-10, 10 means severe pain while 0 means no pain	8 months